About Eyenovia
Eyenovia is a company based in New York (United States) founded in 2014.. Eyenovia has raised $10.04 million across 6 funding rounds from investors including Senju Pharmaceutical, Private Medical Equity and Eshelman Ventures. The company has 14 employees as of December 31, 2024. Eyenovia offers products and services including Optejet. Eyenovia operates in a competitive market with competitors including iVeena Delivery Systems, Kedalion Thera, PolyActiva, Re-Vana Therapeutics and On Demand Therapeutics, among others.
- Headquarter New York, United States
- Employees 14 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hyperion Defi, Inc.
-
Annual Revenue
$57.34 K1414.02as on Dec 31, 2024
-
Net Profit
$-49.82 M-82.75as on Dec 31, 2024
-
EBITDA
$-31.54 M-28.08as on Dec 31, 2024
-
Total Equity Funding
$10.04 M (USD)
in 6 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
Jun 20, 2025
-
Investors
Senju Pharmaceutical
& 3 more
-
Employee Count
14
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Eyenovia
Eyenovia is a publicly listed company on the NASDAQ with ticker symbol HYPD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Eyenovia
Eyenovia offers a comprehensive portfolio of products and services, including Optejet. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers precise microdosing for eye treatments to enhance accuracy.
Unlock access to complete
Unlock access to complete
Funding Insights of Eyenovia
Eyenovia has successfully raised a total of $10.04M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $50.0M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Post-IPO - Eyenovia | Valuation |
investors |
|
| Apr, 2020 | Amount | Post-IPO - Eyenovia | Valuation |
investors |
|
| Aug, 2017 | Amount | Series B - Eyenovia | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eyenovia
Eyenovia has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Senju Pharmaceutical, Private Medical Equity and Eshelman Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investments in biotech and medtech are managed.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Pharmaceutical products are researched, developed, and distributed globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eyenovia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eyenovia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eyenovia Comparisons
Competitors of Eyenovia
Eyenovia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iVeena Delivery Systems, Kedalion Thera, PolyActiva, Re-Vana Therapeutics and On Demand Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ocular drug products for drop-free cataract surgery are developed.
|
|
| domain | founded_year | HQ Location |
Provider of drug delivery system for eye diseases
|
|
| domain | founded_year | HQ Location |
A platform for slow-release, site-specific drug delivery is developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery platform for ophthalmic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Develops laser-activated implants for targeted drug delivery.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eyenovia
Frequently Asked Questions about Eyenovia
When was Eyenovia founded?
Eyenovia was founded in 2014.
Where is Eyenovia located?
Eyenovia is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Eyenovia a funded company?
Eyenovia is a funded company, having raised a total of $10.04M across 6 funding rounds to date. The company's 1st funding round was a Series B of $6M, raised on Oct 01, 2014.
How many employees does Eyenovia have?
As of Dec 31, 2024, the latest employee count at Eyenovia is 14.
What is the annual revenue of Eyenovia?
Annual revenue of Eyenovia is $57.34K as on Dec 31, 2024.
What does Eyenovia do?
Eyenovia was established in 2014 in New York, United States, within the ophthalmology sector. Microdose therapies targeting myopia and presbyopia are developed, supported by an Optejet dispenser that applies MAP technology for precise administration of eye solutions. The pipeline includes candidates such as Micropine, Microline, and Mydcombi, focused on therapeutic delivery innovations. Operations center on advancing these products for clinical use.
Who are the top competitors of Eyenovia?
Eyenovia's top competitors include PolyActiva, iVeena Delivery Systems and Re-Vana Therapeutics.
What products or services does Eyenovia offer?
Eyenovia offers Optejet.
Is Eyenovia publicly traded?
Yes, Eyenovia is publicly traded on NASDAQ under the ticker symbol HYPD.
Who are Eyenovia's investors?
Eyenovia has 4 investors. Key investors include Senju Pharmaceutical, Private Medical Equity, Eshelman Ventures, and unknown.
What is Eyenovia's ticker symbol?
The ticker symbol of Eyenovia is HYPD on NASDAQ.